Kuo Kelly, Caughey Aaron B
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR.
Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR.
Am J Obstet Gynecol. 2016 Oct;215(4):505.e1-5. doi: 10.1016/j.ajog.2016.05.032. Epub 2016 May 27.
Data regarding pregnancy outcomes in sickle cell disease are conflicting. Previous studies are limited by small sample size, narrow geographic area, and a wide range of resource availability.
The purpose of this study was to examine the association between maternal sickle cell disease and adverse pregnancy outcomes in a contemporary North American cohort.
We performed a retrospective cohort study of 2,027,323 women with singleton pregnancies delivered in California from 2005-2008. Deliveries at <24 or >42 6/7 weeks of gestation were excluded. Women with sickle cell disease were compared with control subjects. Maternal outcomes of interest included preeclampsia, preterm delivery, placental abruption, oligohydramnios, and cesarean delivery; neonatal outcomes included small for gestational age, anomalies, stillbirth, neonatal death, and infant death.
The prevalence of sickle cell disease was 0.017%. Compared with control subjects, women with sickle cell disease were more likely to have limited prenatal care (7.4 vs 3.8%; P=.001), underlying chronic hypertension (2.3% vs 1.1%; P=.038), and fetal anomalies (14.0 vs 6.4%; P<.001). The increased odds of fetal anomalies persisted after adjustment for multiple confounders (odds ratio, 1.73; 95% confidence interval, 1.26-2.38). Women with sickle cell disease also had higher odds of severe preeclampsia (odds ratio, 3.75; 95% confidence interval, 2.21-6.38), preterm delivery (odds ratio, 2.50; 95% confidence interval, 1.93-3.21), small for gestational age (odds ratio, 1.96; 95% confidence interval, 1.18-3.25), and cesarean delivery (odds ratio, 1.93; 95% confidence interval, 1.40-2.67).
Women with sickle cell disease are at high risk of maternal and neonatal morbidity. Low rates of fetal and neonatal death may reflect improved antenatal surveillance and management as compared with previous studies. The association between sickle cell disease and fetal anomalies warrants further investigation.
镰状细胞病患者妊娠结局的数据存在矛盾。既往研究受样本量小、地理区域狭窄以及资源可及性差异大的限制。
本研究旨在探讨当代北美队列中母亲患镰状细胞病与不良妊娠结局之间的关联。
我们对2005年至2008年在加利福尼亚州分娩单胎妊娠的2,027,323名妇女进行了一项回顾性队列研究。排除妊娠<24周或>42 6/7周的分娩。将镰状细胞病女性与对照受试者进行比较。感兴趣的母亲结局包括子痫前期、早产、胎盘早剥、羊水过少和剖宫产;新生儿结局包括小于胎龄儿、畸形、死产、新生儿死亡和婴儿死亡。
镰状细胞病的患病率为0.017%。与对照受试者相比,镰状细胞病女性更有可能接受有限的产前检查(7.4%对3.8%;P = 0.001)、患有潜在慢性高血压(2.3%对1.1%;P = 0.038)以及胎儿畸形(14.0%对6.4%;P < 0.001)。在对多个混杂因素进行调整后,胎儿畸形的增加几率仍然存在(比值比,1.73;95%置信区间,1.26 - 2.38)。镰状细胞病女性发生严重子痫前期的几率也更高(比值比,3.75;95%置信区间,2.21 - 6.38)、早产(比值比,2.50;95%置信区间,1.93 - 3.21)、小于胎龄儿(比值比,1.96;95%置信区间,1.18 - 3.25)以及剖宫产(比值比,1.93;95%置信区间,1.40 - 2.67)。
镰状细胞病女性母婴发病风险高。与既往研究相比,胎儿和新生儿死亡率较低可能反映了产前监测和管理的改善。镰状细胞病与胎儿畸形之间的关联值得进一步研究。